SUMICHEMNSESUMITOMO CHEM INDIA LTDMediumNeutral
Announced Mon, 26 Oct, 2026 · 23:15 IST

Q2 revenue and margins fall; H2 outlook remains challenging

Mgmt Guided Margin PressureInvestor Communications View source PDFExplain this filing

SUMICHEM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-4.2%Reaction day
₹354.25
prior close
₹350.00
announcement price
After-mkt
timing
Nifty Smallcap 250market+2.2%-6.4% vs market
Pesticides & Agrochemicals peers, median of 27sector+1.2%-5.5% vs sector

On the reaction day the stock moved 6.4 pts less than Nifty Smallcap 250 and 5.5 pts less than its Pesticides & Agrochemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-4.2
10m
-2.2
15m
-1.3
30m
-3.2
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-4.2+2.2-6.4+1.2-5.5
Next day
-5.5pendingpending+2.3-7.8
2d
—————
3d
—————
4d
—————
5d
—————
1w
—————
15d
—————
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Smallcap 250Sector · Pesticides & Agrochemicals peers, median of 27Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Q2 FY27 revenue fell 2% year on year to Rs 907.3 crore. Operating profit before depreciation, interest and tax fell 15% to Rs 185.8 crore, while profit after tax fell 11% to Rs 157.4 crore. Gross margin was 40.7%. Exports dropped 23%, but domestic sales rose 2%. H1 profit after tax rose 5%, aided by a Rs 26.9 crore insurance claim. Management expects H2 to stay challenging due to low reservoirs, El Nino and possible acreage constraints.

Likely market impact

Near-term earnings and stock sentiment may stay weak due to soft demand, lower exports and margin pressure, though cost alignment offers some support.